{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:13:00Z","timestamp":1787440380802,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-06007-4","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:07:44Z","timestamp":1753438064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Organism profiles and empirical treatments for periprosthetic joint infections"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6960-6363","authenticated-orcid":false,"given":"Gongan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2552-9686","authenticated-orcid":false,"given":"Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"6007_CR1","doi-asserted-by":"publisher","unstructured":"Pulido L, Ghanem E, Joshi A et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008. 466. (7): 1710\u20135.https:\/\/doi.org\/10.1007\/s11999-008-0209-4","DOI":"10.1007\/s11999-008-0209-4"},{"issue":"5","key":"6007_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.arth.2013.09.053","volume":"29","author":"BT Bjerke-Kroll","year":"2014","unstructured":"Bjerke-Kroll BT, Christ AB, McLawhorn AS, et al. Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty. 2014;29(5):877\u201382. https:\/\/doi.org\/10.1016\/j.arth.2013.09.053.","journal-title":"J Arthroplasty"},{"issue":"10","key":"6007_CR3","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1016\/j.arth.2018.05.042","volume":"33","author":"SM Kurtz","year":"2018","unstructured":"Kurtz SM, Lau EC, Son MS, et al. Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the medicare population. J Arthroplasty. 2018;33(10):3238\u201345. https:\/\/doi.org\/10.1016\/j.arth.2018.05.042.","journal-title":"J Arthroplasty"},{"issue":"1","key":"6007_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/07853890.2023.2179105","volume":"55","author":"A Brivio","year":"2023","unstructured":"Brivio A, Al-Jabri T, Martin J, et al. Debridement, antibiotics and implant retention (DAIR) is successful in the management of acutely infected unicompartmental knee arthroplasty: a case series. Ann Med. 2023;55(1):680\u20138. https:\/\/doi.org\/10.1080\/07853890.2023.2179105.","journal-title":"Ann Med"},{"issue":"1","key":"6007_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13018-021-02450-1","volume":"16","author":"S Watanabe","year":"2021","unstructured":"Watanabe S, Kobayashi N, Tomoyama A, et al. Clinical characteristics and risk factors for culture-negative periprosthetic joint infections. J Orthop Surg Res. 2021;16(1):292. https:\/\/doi.org\/10.1186\/s13018-021-02450-1.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6007_CR6","first-page":"30","volume":"28","author":"H Li","year":"2014","unstructured":"Li H, Yang R, Geng L, et al. Clinical characters of culture-negative prosthetic joint infection. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014;28(1):30\u20133.","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"key":"6007_CR7","doi-asserted-by":"publisher","unstructured":"Ji B, Li G, Zhang X, et al. Effective treatment of single-stage revision using intra-articular antibiotic infusion for culture-negative prosthetic joint infection. Bone Joint J. 2020;3102\u2013B. https:\/\/doi.org\/10.1302\/0301-620X.102B3.BJJ-2019-0820.R1.","DOI":"10.1302\/0301-620X.102B3.BJJ-2019-0820.R1"},{"issue":"1","key":"6007_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40001-023-01138-y","volume":"28","author":"F Migliorini","year":"2023","unstructured":"Migliorini F, Weber CD, Bell A, et al. Bacterial pathogens and in-hospital mortality in revision surgery for periprosthetic joint infection of the hip and knee: analysis of 346 patients. Eur J Med Res. 2023;28(1):177. https:\/\/doi.org\/10.1186\/s40001-023-01138-y.","journal-title":"Eur J Med Res"},{"issue":"2","key":"6007_CR9","first-page":"245","volume":"75","author":"G Walley","year":"2009","unstructured":"Walley G, Orendi J, Bridgman S, et al. Methicillin resistant Staphylococcus aureus (MRSA) is not always caught on the orthopaedic ward. Acta Orthop Belg. 2009;75(2):245\u201351.","journal-title":"Acta Orthop Belg"},{"key":"6007_CR10","unstructured":"Lombardo MDM, Maffulli N, Bassani R et al. Periprosthetic joint infection from Mycobacterium Tuberculosis in Togo, Africa. J Biol Regul Homeost Agents. 2020. 34. (4 Suppl. 3): 114\u2013118 Congress of the Italian Orthopaedic Research Society.DOI."},{"issue":"5","key":"6007_CR11","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","volume":"33","author":"J Parvizi","year":"2018","unstructured":"Parvizi J, Tan TL, Goswami K, et al. The 2018 definition of periprosthetic hip and knee infection: an Evidence-Based and validated criteria. J Arthroplasty. 2018;33(5):1309\u2013e13142. https:\/\/doi.org\/10.1016\/j.arth.2018.02.078.","journal-title":"J Arthroplasty"},{"key":"6007_CR12","doi-asserted-by":"publisher","unstructured":"McNally M, Sousa R, Wouthuyzen-Bakker M, et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021;1103\u2013B. https:\/\/doi.org\/10.1302\/0301-620X.103B1.BJJ-2020-1381.R1.","DOI":"10.1302\/0301-620X.103B1.BJJ-2020-1381.R1"},{"issue":"20","key":"6007_CR13","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2106\/JBJS.16.00719","volume":"98","author":"B Graham","year":"2016","unstructured":"Graham B, Peljovich AE, Afra R, et al. The American academy of orthopaedic surgeons Evidence-Based clinical practice guideline on: management of carpal tunnel syndrome. J Bone Joint Surg Am. 2016;98(20):1750\u20134. https:\/\/doi.org\/10.2106\/JBJS.16.00719.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"6007_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1128\/JCM.01762-07","volume":"46","author":"J Esteban","year":"2008","unstructured":"Esteban J, Gomez-Barrena E, Cordero J, et al. Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J Clin Microbiol. 2008;46(2):488\u201392. https:\/\/doi.org\/10.1128\/JCM.01762-07.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"6007_CR15","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00264-018-3827-9","volume":"42","author":"Z Huang","year":"2018","unstructured":"Huang Z, Wu Q, Fang X, et al. Comparison of culture and broad-range polymerase chain reaction methods for diagnosing periprosthetic joint infection: analysis of joint fluid, periprosthetic tissue, and sonicated fluid. Int Orthop. 2018;42(9):2035\u201340. https:\/\/doi.org\/10.1007\/s00264-018-3827-9.","journal-title":"Int Orthop"},{"key":"6007_CR16","doi-asserted-by":"publisher","unstructured":"Weinstein MP, Lewis JS 2. The clinical and laboratory standards Institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;358. https:\/\/doi.org\/10.1128\/JCM.01864-19.","DOI":"10.1128\/JCM.01864-19"},{"issue":"1","key":"6007_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2007.01.007","volume":"55","author":"E Moran","year":"2007","unstructured":"Moran E, Masters S, Berendt AR, et al. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007;55(1):1\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2007.01.007.","journal-title":"J Infect"},{"issue":"8","key":"6007_CR18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.clinthera.2006.08.001","volume":"28","author":"E Senneville","year":"2006","unstructured":"Senneville E, Legout L, Valette M, et al. Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther. 2006;28(8):1155\u201363. https:\/\/doi.org\/10.1016\/j.clinthera.2006.08.001.","journal-title":"Clin Ther"},{"issue":"6","key":"6007_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2106\/JBJS.E.00004","volume":"88","author":"E Fulkerson","year":"2006","unstructured":"Fulkerson E, Valle CJ, Wise B, et al. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am. 2006;88(6):1231\u20137. https:\/\/doi.org\/10.2106\/JBJS.E.00004.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"6007_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jinf.2022.07.009","volume":"85","author":"A Casenaz","year":"2022","unstructured":"Casenaz A, Piroth L, Labattut L, et al. Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study. J Infect. 2022;85(5):492\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2022.07.009.","journal-title":"J Infect"},{"key":"6007_CR21","doi-asserted-by":"publisher","unstructured":"Zimmerli W, Sendi P. Role of Rifampin against Staphylococcal biofilm infections in vitro, in animal models, and in Orthopedic-Device-Related infections. Antimicrob Agents Chemother. 2019;63(2). https:\/\/doi.org\/10.1128\/AAC.01746-18.","DOI":"10.1128\/AAC.01746-18"},{"key":"6007_CR22","doi-asserted-by":"publisher","unstructured":"Chang Y, Li Y, Fan T, et al. Pathogenic bacteria characteristics and drug resistance in acute, delayed, and chronic periprosthetic joint infection: A retrospective analysis of 202 patients. Int Wound J. 2023;820. https:\/\/doi.org\/10.1111\/iwj.14212.","DOI":"10.1111\/iwj.14212"},{"key":"6007_CR23","doi-asserted-by":"publisher","unstructured":"Hu L, Fu J, Zhou Y, et al. Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study. J Back Musculoskelet Rehabil. 2023;136. https:\/\/doi.org\/10.3233\/BMR-210319.","DOI":"10.3233\/BMR-210319"},{"issue":"1","key":"6007_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12891-023-06210-6","volume":"24","author":"T Ma","year":"2023","unstructured":"Ma T, Lyu J, Ma J, et al. Comparative analysis of pathogen distribution in patients with fracture-related infection and periprosthetic joint infection: a retrospective study. BMC Musculoskelet Disord. 2023;24(1):123. https:\/\/doi.org\/10.1186\/s12891-023-06210-6.","journal-title":"BMC Musculoskelet Disord"},{"key":"6007_CR25","doi-asserted-by":"publisher","unstructured":"Yu Y, Kong Y, Ye J, et al. Microbiological pattern of prosthetic hip and knee infections: a high-volume, single-centre experience in China. J Med Microbiol. 2021;370. https:\/\/doi.org\/10.1099\/jmm.0.001305.","DOI":"10.1099\/jmm.0.001305"},{"key":"6007_CR26","doi-asserted-by":"publisher","unstructured":"Chotanaphuti T, Courtney PM, Fram B et al. Hip and Knee Section, Treatment, Algorithm: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019. 34. (2S): S393-S397.https:\/\/doi.org\/10.1016\/j.arth.2018.09.024","DOI":"10.1016\/j.arth.2018.09.024"},{"key":"6007_CR27","doi-asserted-by":"publisher","unstructured":"Benito N, Mur I, Ribera A, et al. The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of Multidrug-Resistant organisms. J Clin Med. 2019;58. https:\/\/doi.org\/10.3390\/jcm8050673.","DOI":"10.3390\/jcm8050673"},{"issue":"2","key":"6007_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cmi.2021.06.006","volume":"28","author":"DBG Tai","year":"2022","unstructured":"Tai DBG, Patel R, Abdel MP, et al. Microbiology of hip and knee periprosthetic joint infections: a database study. Clin Microbiol Infect. 2022;28(2):255\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.006.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"6007_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.joca.2016.12.010","volume":"25","author":"PH Gundtoft","year":"2017","unstructured":"Gundtoft PH, Pedersen AB, Schonheyder HC, et al. One-year incidence of prosthetic joint infection in total hip arthroplasty: a cohort study with linkage of the Danish hip arthroplasty register and Danish microbiology databases. Osteoarthritis Cartilage. 2017;25(5):685\u201393. https:\/\/doi.org\/10.1016\/j.joca.2016.12.010.","journal-title":"Osteoarthritis Cartilage"},{"issue":"26","key":"6007_CR30","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1016\/j.biomaterials.2012.05.031","volume":"33","author":"CR Arciola","year":"2012","unstructured":"Arciola CR, Campoccia D, Speziale P, et al. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 2012;33(26):5967\u201382. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.05.031.","journal-title":"Biomaterials"},{"issue":"9","key":"6007_CR31","first-page":"103390antibioti","volume":"11","author":"F Froschen","year":"2022","unstructured":"Froschen F, Randau S, M T, Franz A, et al. Microbiological trends and antibiotic susceptibility patterns in patients with periprosthetic joint infection of the hip or knee over 6 years. Antibiot (Basel). 2022;11(9):103390antibiotics11091244.","journal-title":"Antibiot (Basel)"},{"issue":"6 Supple A","key":"6007_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1302\/0301-620X.103B6.BJJ-2020-1923.R1","volume":"103\u2013B","author":"A Klasan","year":"2021","unstructured":"Klasan A, Schermuksnies A, Gerber F, et al. Development of antibiotic resistance in periprosthetic joint infection after total knee arthroplasty. Bone Joint J. 2021;103\u2013B(6 Supple A):171\u20136. https:\/\/doi.org\/10.1302\/0301-620X.103B6.BJJ-2020-1923.R1.","journal-title":"Bone Joint J"},{"issue":"5","key":"6007_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1055\/s-0033-1364102","volume":"27","author":"VK Aggarwal","year":"2014","unstructured":"Aggarwal VK, Bakhshi H, Ecker NU, et al. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the united States. J Knee Surg. 2014;27(5):399\u2013406. https:\/\/doi.org\/10.1055\/s-0033-1364102.","journal-title":"J Knee Surg"},{"key":"6007_CR34","doi-asserted-by":"crossref","unstructured":"Rupp M, Baertl S, Walter N et al. Is there a difference in Microbiological epidemiology and effective empiric antimicrobial therapy comparing Fracture-Related infection and periprosthetic joint infection? A retrospective comparative study. Antibiotics (Basel). 2021. 10. (8).","DOI":"10.3390\/antibiotics10080921"},{"issue":"11","key":"6007_CR35","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00402-021-04139-w","volume":"141","author":"P Preobrazhensky","year":"2021","unstructured":"Preobrazhensky P, Bozhkova S, Kochish A, et al. Comparative analysis of pathogen structure in patients with PJI after primary total hip and knee arthroplasty. Arch Orthop Trauma Surg. 2021;141(11):1963\u20139. https:\/\/doi.org\/10.1007\/s00402-021-04139-w.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"6007_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00590-021-03156-0","volume":"33","author":"R Scholten","year":"2023","unstructured":"Scholten R, Klein Klouwenberg PMC, Gisolf JEH, et al. Empiric antibiotic therapy in early periprosthetic joint infection: a retrospective cohort study. Eur J Orthop Surg Traumatol. 2023;33(1):29\u201335. https:\/\/doi.org\/10.1007\/s00590-021-03156-0.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"6007_CR37","doi-asserted-by":"publisher","unstructured":"Roman MD, Bocea BA, Ion NI, et al. Are there any changes in the causative microorganisms isolated in the last years from hip and knee periprosthetic joint infections?? Antimicrobial susceptibility test results analysis. Microorganisms. 2023;11(1). https:\/\/doi.org\/10.3390\/microorganisms11010116.","DOI":"10.3390\/microorganisms11010116"},{"key":"6007_CR38","doi-asserted-by":"publisher","unstructured":"Froschen FS, Randau TM, Franz A, et al. Microbiological profiles of patients with periprosthetic joint infection of the hip or knee. Diagnostics (Basel). 2022;12(7). https:\/\/doi.org\/10.3390\/diagnostics12071654.","DOI":"10.3390\/diagnostics12071654"},{"issue":"1","key":"6007_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12879-022-07532-x","volume":"22","author":"Y Kherabi","year":"2022","unstructured":"Kherabi Y, Zeller V, Kerroumi Y, et al. Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different? BMC Infect Dis. 2022;22(1):555. https:\/\/doi.org\/10.1186\/s12879-022-07532-x.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"6007_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1302\/0301-620x.86b2.14129","volume":"86","author":"SS Mohanty","year":"2004","unstructured":"Mohanty SS, Kay PR. Infection in total joint replacements. Why we screen MRSA when MRSE is the problem? J Bone Joint Surg Br. 2004;86(2):266\u20138. https:\/\/doi.org\/10.1302\/0301-620x.86b2.14129.","journal-title":"J Bone Joint Surg Br"},{"key":"6007_CR41","doi-asserted-by":"publisher","unstructured":"Hendriks JG, van Horn JR, van der Mei HC, et al. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. Biomaterials. 2004;325. https:\/\/doi.org\/10.1016\/s0142-9612(03)00554-4.","DOI":"10.1016\/s0142-9612(03)00554-4"},{"issue":"1 Suppl A","key":"6007_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1302\/0301-620X.98B.36276","volume":"98\u2013B","author":"LA Whiteside","year":"2016","unstructured":"Whiteside LA, Roy ME, Nayfeh TA. Intra-articular infusion: a direct approach to treatment of infected total knee arthroplasty. Bone Joint J. 2016;98\u2013B(1 Suppl A):31\u20136. https:\/\/doi.org\/10.1302\/0301-620X.98B.36276.","journal-title":"Bone Joint J"},{"key":"6007_CR43","doi-asserted-by":"publisher","unstructured":"Li ZL, Hou YF, Zhang BQ, et al. Identifying common pathogens in periprosthetic joint infection and testing Drug-resistance rate for different antibiotics: A prospective, single center study in Beijing. Orthop Surg. 2018;310. https:\/\/doi.org\/10.1111\/os.12394.","DOI":"10.1111\/os.12394"},{"issue":"1","key":"6007_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1179\/joc.2008.20.1.53","volume":"20","author":"O Kandemir","year":"2008","unstructured":"Kandemir O, Oztuna V, Colak M, et al. Comparison of the efficacy of Tigecycline and Teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model. J Chemother. 2008;20(1):53\u20137. https:\/\/doi.org\/10.1179\/joc.2008.20.1.53.","journal-title":"J Chemother"},{"issue":"12","key":"6007_CR45","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/apm.12465","volume":"123","author":"T Hamad","year":"2015","unstructured":"Hamad T, Hellmark B, Nilsdotter-Augustinsson A, et al. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on Doxycycline. APMIS. 2015;123(12):1055\u201360. https:\/\/doi.org\/10.1111\/apm.12465.","journal-title":"APMIS"},{"issue":"2","key":"6007_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/joim.12233","volume":"276","author":"W Zimmerli","year":"2014","unstructured":"Zimmerli W. Clinical presentation and treatment of orthopaedic implant-associated infection. J Intern Med. 2014;276(2):111\u20139. https:\/\/doi.org\/10.1111\/joim.12233.","journal-title":"J Intern Med"},{"issue":"10","key":"6007_CR47","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/cid\/cis027","volume":"54","author":"T Crawford","year":"2012","unstructured":"Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis? Clin Infect Dis. 2012;54(10):1474\u20139. https:\/\/doi.org\/10.1093\/cid\/cis027.","journal-title":"Clin Infect Dis"},{"key":"6007_CR48","doi-asserted-by":"publisher","unstructured":"Tornero E, Garcia-Ramiro S, Martinez-Pastor JC, et al. Prophylaxis with Teicoplanin and Cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty. Antimicrob Agents Chemother. 2015;259. https:\/\/doi.org\/10.1128\/AAC.03949-14.","DOI":"10.1128\/AAC.03949-14"},{"key":"6007_CR49","doi-asserted-by":"publisher","unstructured":"He JW, Wang J, Cao L, et al. Serum and synovial Vancomycin concentrations in patients with prosthetic joint infection after Intra-articular infusion. Eur J Drug Metab Pharmacokinet. 2021;546. https:\/\/doi.org\/10.1007\/s13318-021-00705-0.","DOI":"10.1007\/s13318-021-00705-0"},{"key":"6007_CR50","doi-asserted-by":"crossref","unstructured":"Zhou Y-F, Xiong YQ, Tao M-T et al. Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA. Journal of Antimicrobial Chemotherapy. 2018. 73. (7): 1899\u20131907. Journal of Antimicrobial Chemotherapy.","DOI":"10.1093\/jac\/dky129"},{"issue":"7","key":"6007_CR51","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1128\/AAC.00120-07","volume":"51","author":"A Trampuz","year":"2007","unstructured":"Trampuz A, Murphy CK, Rothstein DM, et al. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother. 2007;51(7):2540\u20135. https:\/\/doi.org\/10.1128\/AAC.00120-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"6007_CR52","doi-asserted-by":"publisher","unstructured":"Zimmerli W, Widmer AF, Blatter M, et al. Role of Rifampin for treatment of orthopedic implant-related Staphylococcal infections: a randomized controlled trial. Foreign-Body infection (FBI) study group. JAMA. 1998;19279. https:\/\/doi.org\/10.1001\/jama.279.19.1537.","DOI":"10.1001\/jama.279.19.1537"},{"issue":"1","key":"6007_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7150\/jbji.40333","volume":"5","author":"A Becker","year":"2020","unstructured":"Becker A, Kreitmann L, Triffaut-Fillit C, et al. Duration of Rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France. J Bone Jt Infect. 2020;5(1):28\u201334. https:\/\/doi.org\/10.7150\/jbji.40333.","journal-title":"J Bone Jt Infect"},{"issue":"8","key":"6007_CR54","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10096-010-0952-9","volume":"29","author":"OC El Helou","year":"2010","unstructured":"El Helou OC, Berbari EF, Lahr BD, et al. Efficacy and safety of Rifampin containing regimen for Staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010;29(8):961\u20137. https:\/\/doi.org\/10.1007\/s10096-010-0952-9.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06007-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:07:46Z","timestamp":1753438066000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-06007-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6007"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06007-4","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"698"}}